Hodgkin’s lymphoma

Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The lymphatic system includes the lymph nodes or glands, [...]

Brain tumors: Diagnosis and treatment  Brain tumors can begin in your brain (primary brain tumors), or cancer can begin in other parts of your [...]

Lymphoma: An overview  Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. Your treatment [...]

As a professional makeup artist, Adrian Rios is used to working in a variety of settings, from fashion shows and speaking events to photoshoots and [...]

Kristine Long, a patient at Mayo Clinic's Arizona campus, has had an incredible journey as a three-time Hodgkin's lymphoma survivor. In [...]

ROCHESTER, Minn. — A phase I clinical trial of nivolumab found that the immune-boosting drug is a highly effective therapy for Hodgkin’s lymphoma. The multi-institution study, led by Mayo Clinic, indicated that the drug was safe and led to an 87 percent response rate in patients who had failed on other treatments. Results of the study appear in the New England Journal of Medicine. https://www.youtube.com/watch?v=omfyts8WFTo&feature=youtu.be The findings support further development of nivolumab, which enhances the immune system’s ability to detect and kill cancer cells. The drug has already demonstrated benefit in the treatment of other cancers, particularly melanoma, renal cell cancer, lung cancer and bladder cancer. “Nivolumab is a very promising agent that is reasonably well-tolerated and can easily be combined with other agents in the future,” says Stephen Ansell, M.D., Ph.D., a hematologist and co-lead author of the study. “There is evidence now that you can fight cancer by optimizing your immune function, either by enhancing signals that stimulate the immune response or blocking signals that dampen it.”

Meditate in nature to help relieve stress of cancer fight A few minutes a day spent outdoors [...]

It’s tough for anyone to deal with a cancer diagnosis, especially someone at the age of 18. Todd Blake, a Jacksonville, Fla., native, was just beginning life as a freshman at the University of Florida when he was diagnosed with late-stage Hodgkin’s Lymphoma, a serious form of blood cancer. Fast-forward through countless treatments and multiple relapses, Todd decided to make the most of his situation by starting a nonprofit organization to help other young adults deal with their cancer diagnosis. Now, his wife, Maja, has  joined the battle against cancer — recently joining Mayo Clinic’s Cancer Center research team and pursuing future cures for several types of blood cancer.